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Efficacy of brief person-centered cognitive behavioral therapy  
to facilitate self-management for patients with Rheumatoid Arthritis:  
a mixed methods case series feasibility study 
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Abstract  
The psychological consequences of living with Rheumatoid Arthritis (RA) are commonly 
reported by patients. The objectives of this study were:  (i) to investigate views of patients with 
RA about the provision of psychological support; and (ii) to study the efficacy of a person-
centred cognitive behavioural therapy (CBT) self-management approach, including a health 
economic investigation to explore the service use and costs related to treatment in patients with 
RA. A mixed methods was applied: a formative qualitative interview study and a quantitative 
CBT intervention outcome assessment together formed the case series feasibility study design, 
including a health economic investigation. The qualitative study highlighted that patients 
would welcome emotional support. The CBT intervention from a small sample suggested that 
participants may have benefitted from the intervention at the endpoint of the follow-up. The 
results of the economic component need to be interpreted with caution in relation to service 
gaps. A broad approach in the delivery of a psychological intervention may benefit patients 
with long-term conditions, such as RA. The practice implications of these results are that RA 
patients may benefit from psychological interventions to cope better with their long-term 
condition through face to face intervention with a flexible appointment system. Intervention 
studies are necessary to test this question in detail in the future. 
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Efficacy of brief person-centered cognitive behavioral therapy  
to facilitate self-management for patients with Rheumatoid Arthritis:  
a mixed methods case series feasibility study 
 
Introduction  
Rheumatoid Arthritis (RA) is a systemic, long-term inflammatory autoimmune disease that can 
lead to progressive and irreversible destruction of the joints. It affects 0.5% to 1% of adults in 
high income countries, whose prevalence is commonly between the fourth and sixth decades 
of life, and occurs three times more often in women than men. RA costs the National Health 
Service (NHS) in Britain over £680 million each year (Scott, Wolfe, & Huizinga, 2010). If 
untreated this chronic condition decreases quality of life, compromises the ability to perform 
everyday activities, and increases work absenteeism.  
Early diagnosis and prompt intensive treatment are key components to alter the disease course 
and prognosis (Singh, Christensen, Wells, Suarez-Almazor, & et.al., 2009; Smolen et al., 2010; 
The National Institute for Health and Care Excellence, 2009). A range of indicators are used to 
assess RA status that incorporates patients’ priorities for their management and care. Patients 
frequently rate continuity of work, less sleep disturbance, reducing debilitating fatigue and 
long-term pain as important (Kwoh & Ibrahim, 2001). Optimal treatment is recommended to 
be provided by a multi-disciplinary team, psycho-social support, exercise, drug treatment, 
regular blood monitoring, and joint surgery in late disease stages (The National Institute for 
Health and Care Excellence, 2009).  
The pharmacological treatment options consist of analgesics, non-steroidal inflammatory 
drugs, one or more disease modifying anti-rheumatic drugs (DMARDs) such as methotrexate, 
or biologic DMARDs, e.g. tumour necrosis factor (TNF) inhibitors (Singh et al., 2009; The 
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National Institute for Health and Care Excellence, 2009) . The key challenges of RA remain: 
(i) the unpredictability of the acute ‘flare-ups’ (i.e. clinical exacerbations of joint 
inflammation); and (ii) how individual patients respond to the medications. Control over the 
illness is therefore often uncertain. Patients and professionals need to closely collaborate and 
continuously adapt to the disease state and the psycho-social situation of each patient (Simpson, 
Franks, Morrison, & Lempp, 2005).  
The need for psychological interventions in RA 
The consequences of RA include: depression, anxiety, fatigue, pain, poor sleep, reduced 
physical activity, and impaired quality of life have been identified in national, European and 
international treatment guidelines (Forestier, Andre-Vert, Guillez, & al., 2009; Luqmani, 
Hennell, Estrach, & al., 2006, 2009; The National Insitute for Health and Care Excellence, 
2007). A number of recent publications have drawn attention to the need for psycho-social 
support (Ang, Choi, Kroenke, & Wolfe, 2005; Dures et al., 2014; Gettings, 2010; Lempp et al., 
2011; Lempp et al., 2009; Polsky et al., 2005; The National Institute for Health and Care 
Excellence, 2009). A systematic review and meta-analysis of adjunct psycho-social 
interventions (Dissanayake & Bertouch, 2010)  identified the prevalence of major depression 
within the range of 17-38%. Other studies have confirmed these findings and reported a 2.0 to 
3.5-fold higher rate of depression in RA than in the general population (Ang et al., 2005; Polsky 
et al., 2005). These high prevalence rates are associated with poorer RA outcomes. The early 
detection and treatment of co-morbid mental disorders are therefore indicated as part of an 
integrated treatment package for people with RA. (Matcham, Rayner, Steer, & Hotopf, 2013). 
Another important feature is that of ‘diagnostic overshadowing’ (Jones, Howard, & 
Thornicroft, 2008) known in the field of mental health, when specialist practitioners tend to 
focus upon the primary presenting physical condition, rather than assessing the whole range of 
physical and psycho-social needs of each patient.  
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Effectiveness of cognitive behavioural therapy in RA  
While the psychological impact of long-term conditions such as RA is significant  (Lineker, 
Badley, Charles, Hart, & Streiner, 1999), it has been suggested that not enough is known about 
the effectiveness of psychological treatments such as CBT for RA (Pilling, Anderson, 
Goldberg, Meader, & Taylor, 2009; Rizzo, Creed, Goldberg, Meader, & Pilling, 2011). The 
National Institute for Health and Care Excellence (NICE) guidance for adults with depression 
(The National Institute for Health and Care Excellence, 2004), for example, recommends CBT 
rather than drugs as first-line treatment for mild to moderate depression. Despite such 
endorsements, service provision for psychological support is often less than adequate, 
especially in rheumatology out-patient departments in the UK, due to lack of resources 
(Gettings, 2008; Hewlett et al., 2011; Steward & Land, 2009). In the management of 
inflammatory arthritis, such as RA, the focus is usually on pharmacological treatment, which 
seeks to reduce  inflammation and structural joint damage. However, patients often report 
symptoms such as pain and fatigue for example, that can cause considerable psychological 
distress (Dickens, McGowan, Clark-Carter, & Creed, 2002; Pincus, Griffith, Pearce, & 
Isenberg, 1996; Soderlin, Hakala, & Nieminen, 2000).  
In RA, CBT has been shown to significantly reduce depressive symptoms and anxiety when 
compared to routine medical management (Sharpe, Sensky, Timberlake, Ryan, & et al., 2003). 
Sharpe et al studied newly diagnosed patients with RA. In their sample the disability was 
improved in 30% of patients in the CBT group versus 10% of patients in the control group. 
Evers et al (2002) also demonstrated a significant benefit in the group that had the addition of 
CBT to standard medical care, and found that fatigue was significantly decreased at post-
treatment and six-month follow-up points in the CBT study arm only. More recent work by 
Hewlett et al. (2011) compared group CBT for fatigue self-management in RA versus group 
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educational sessions (n=127). Results from this study highlighted that there was a positive 
group CBT effect on participants’ ‘fatigue impact’, their ability to cope, perceived severity of 
the condition and on well-being.    
Pilot study 
Prior to this feasibility study, first we undertook a pilot project to assess whether CBT improves 
medication adherence in RA (Ferguson et al., 2015). The results showed that the intervention 
group demonstrated significant improvement in mean scores on adherence. However, for the 
majority concordance  was not a major issue and participants gave greater priority to: (i) 
managing fatigue in relation to their prescribed medications and RA; (ii)  coping with, and 
adjusting to, the long-term condition; and (iii) experiences of mood changes (i.e. depression 
and anxiety). Patients suggested that self-management of their long-term condition should be 
the focus of the second phase of the study, which is in line with a recent UK governmental 
target (Department of Health., 2006)  .  
Aims of the study 
Against this background, the main aims of this mixed methods  (case series)  study  were  to: 
(i) to investigate the views of patients about the provision of psychological support as part of a 
comprehensive rheumatology outpatient service; and (ii) to assess the efficacy of a person-
centred CBT self-management approach in patients with established RA. (Carey & Boden, 
2003; Kooistra, Dijkman, Einhorn, & Bhandari, 2009; The National Institute for Health and 
Care Excellence, 2009). We framed this aim in terms of the principal question to be addressed: 
Can a psychological intervention based on CBT improve the quality of life for patients with 
RA?   
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We also investigated the following secondary aims:  (i) to assess whether a CBT-based 
psychological intervention can have a positive impact on the presentation of pain, fatigue, and 
the emotional status of the person with RA; and (ii) what are CBT-based intervention inputs 
and other health care and social care services and costs. 
Method    
The study design was mixed methods that consisted mainly of a case series that aims to 
investigate the feasibility of implementing CBT for patients with RA who also experience a 
clinically relevant degree of anxiety/depression. Case studies follow a group of patients with 
the same diagnosis who undergo the same intervention over the study period. They are 
descriptive studies that can generate hypotheses for future interventional or analytical 
investigations (Carey & Boden, 2003; Grimes & Schulz, 2002), and have been applied for other 
psychological interventions (Cortina, Somers, Rohan, & Drotar, 2013; Dugas & Ladouceur, 
2000; Labrecque, Marchand, Dugas, & Letarte, 2007; Silverman, Hains, Davies, & Parton, 
2003). In parallel, we conducted a formative qualitative study to identify patients’ views about 
their needs for emotional support as part of a comprehensive outpatient service. Finally, we 
carried out a health economics investigation of the CBT therapist inputs and other health and 
social care service provision and costs. Research Ethics Committee (NRESNr.12/LO/1015 
London) and Research and Development (RJ112/N289) approval was obtained for the CBT 
intervention and the health economics investigation. 
 
Qualitative study 
To answer the first study objective, we conducted a formative qualitative study through 
individual telephone interviews over a six month period in 2014 to establish the view from 
twelve patients about the need for emotional support when living with RA. The sample size 
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was reached when thematic saturation was achieved (i.e. gathering of new data did not reveal 
new information). Participants were recruited by outpatient clinic staff and participants were 
stratified by gender, age, ethnicity and disease duration. The interview schedule was developed 
from the literature (Dures et al., 2014; Ferguson et al., 2015) and from the experiential 
knowledge of clinic staff. The questions asked included issues identified as being of importance 
to patients related to: accessing emotional support; preference for the mode of service delivery 
e.g. group, face to face, telephone; location, and past experiences of receipt of emotional 
support and its impact. All interviews were carried out by one qualitative researcher (HL) and 
took on average 20 minutes. All patients provided written informed consent prior to the audio-
recording.  
CBT intervention study 
Recruitment 
Participants were recruited from consecutive attendees of one tertiary Rheumatology 
Outpatient Clinic in England. Initial screening was conducted by a Research Assistant (PD).  
Inclusion criteria 
● Male and female patients > 18 years of age with a diagnosis of established RA (> 2 
years of duration). 
● Disease activity score (DAS-28) of 3.2 or above (indicating moderate or severe disease 
activity) (Dougados, Aletaha, & van Riel, 2007). 
● Score of over 7 for anxiety or depression on the Hospital Anxiety and Depression Scale 
(HADS) (Huston, 1987), indicating probable clinically relevant levels of mental health 
co-morbidity.  
Exclusion criteria 
8 
 
● RA with multiple co-morbidities. 
● Presence of significant learning disability /difficulty. 
● Serious co-morbidities making participation in the study difficult (e.g. cardiac failure 
or severe psychiatric presentations). 
● Currently receiving other psychological support or therapy.  
Suitable patients were invited to consider participation in the study following a full assessment 
by the Study Psychologist (EW), if they were deemed by their supervising rheumatologist as 
likely to benefit from the intervention. These individuals were then invited to the study.  
Baseline assessment for the CBT intervention study entailed two parts: The first part comprised 
of the completion of 6 questionnaires and 5 Visual Analogue Scales (VAS), including health 
and social care service use data as shown in Table 1, administered by the Research Assistant. 
(Table 1 about here) 
The second part of the assessment included an individual, person-centered in depth 
consultation carried out by the Study Psychologist. In line with standard clinical assessments, 
these consisted of: (i) gathering information about each patient’s current symptoms; (ii) the 
impact of these on their lives; (iii) their current social situation (e.g. employment status, 
relationships); (iv) relevant background history; and (v) their goals for change if they were to 
take part in the study. Also each patient had the opportunity to ask more detailed questions 
about the study and the intervention.  
Intervention 
The intervention took the form of a person-centered, brief CBT-based approach. Participants 
attended up to six sessions in total, each of which lasted between 30-60 minutes. The frequency 
of the sessions was scheduled between weekly to 3-weekly to allow flexibility, to accommodate 
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the unpredictability of disease progress (e.g. flare ups, severe fatigue) and unforeseen personal 
live events (e. g. childcare difficulties, urgent hospital attendance). 
Each individualized intervention was informed by the CBT training and clinical experience of 
the Study Psychologist, guided by the specific study manual (Sharpe et al., 2003).  
The intervention used in the study was based on the cognitive-behavioral therapy (CBT) 
model. 
In line with standard clinical assessments, information was gathered about: participants’ 
current symptoms; the impact of rheumatoid arthritis on their lives - including on engagement 
in valued activities and on mood; current situation (employment, relationships, living 
circumstances etc); relevant background history. 
The Study Psychologist and each participant agreed on some specific areas the participant 
would like to work on during the intervention. The focus of interventions was tailored to each 
participant, informed by each individual’s circumstances and preferences. A formulation was 
developed with each participant. Formulations provide a working, hypothetical model of how 
an individual’s difficulties relate to each other and how they may have developed and/or be 
maintained. They are open to revision throughout an intervention, and allow areas for 
intervention to be identified.  
Areas of focus chosen included:  
● adjustment/acceptance of RA;  
● understanding and management of symptoms including pain and fatigue;  
● ways to approach activity; 
● stress and mood management;  
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● sleep disturbance;  
● communication and relationships; 
Sessions were each between 30 and 60 minutes long, depending on participant preference. 
Breaks were built into sessions and participants were invited to move about regularly if this 
was helpful, rather than sit for long periods. 
One or two areas were focused on in each session. An agenda was set at the beginning of each 
session in collaboration with the participant. Sessions often entail some education (e.g. goal 
setting, problem-solving strategies, and good sleep hygiene), some psycho-education and 
some practice of new skills (e.g. relaxation, assertiveness). As part of the CBT approach, 
psycho-education includes working on understanding the way body sensations, emotions, 
thoughts and behaviors are related. Areas for intervention may include setting goals to change 
behaviors, identifying unhelpful thoughts and developing alternative responses to these.  
Tasks between sessions earlier in therapy might include monitoring/information-gathering 
relevant to an area of focus for a participant (e.g. collecting information on experience of pain, 
activity, sleep or thoughts each day between sessions). This allows for patterns and links to be 
established, and ways to make changes in these areas to be identified. Tasks between later 
sessions might include making behavioral changes (e.g. approaching activity or sleep 
differently) or practicing skills learnt in sessions, such as relaxation or identifying and 
challenging unhelpful thoughts. A ‘blueprint’ was developed with participants at the end of the 
intervention for them to take away, summarizing what they had found helpful and how they 
intended to maintain or build on helpful changes they had made. (Sharpe et al., 2003). Before 
each meeting, questionnaires were completed as shown in Table 1. 
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Following the end of the main intervention, at two further time-points, quantitative data were 
collected from participants, namely six weeks (the five VAS sub-scales), and six months after 
the end of the intervention (5 VAS scores, 6 questionnaires, and the health economic measures). 
Health economics  
There is a dearth of information on services use and costs in this population. The health 
economic information provided in this feasibility study will make much needed knowledge on 
resource use profiles of individuals treated with CBT for RA available. Information such as 
this will be helpful to   feed into modelling studies of the cost-effectiveness of the application 
of CBT in this population,  which is needed by decision makers who specify recommendations 
on treatment options within health and social care (The National Insitute for Health and Care 
Excellence, 2012).  
To explore the costs of care for patients with RA, health and social services used by study 
participants were identified, using an adapted version of the Client Service Receipt Inventory 
(CSRI) (Beecham & Knapp, 1992). The health economic data were gathered by the Research 
Assistant at three time points (see Table 1). The data focused on hospital-based services 
(inpatient services, outpatient services and accident and emergency visits) as these services 
usually contribute the most to care costs. Health and community based services that are most 
widely used by patients with RA (family doctor, practice nurse, rheumatology specialist nurse, 
occupational therapist and social worker) were also reported. In addition, data on the time the 
study psychologist spent with patients directly or indirectly was also collected. Health and 
social care costs for each patient were estimated by combining their service use data with 
relevant national unit costs for 2013/2014 (Curtis, 2014), obtained from the Personal Social 
Services Research Unit compendium and the NHS Reference Costs 2013 (Department of 
Health., 2013).  
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Data analysis 
Qualitative data analysis of interview study 
Following transcription, a thematic framework analysis was conducted to identify emerging 
themes from patients’ interviews (Ritchie & Spencer, 1994; Spencer, Ritchie, & O'Connor, 
2003). The data were validated by: (i) a random sample of two transcriptions were 
independently coded by an external qualitative researcher; (ii) the use of single counting (Seale, 
1999b) , inclusion of negative instances (Seale, 1999a) ;  and (iii)  presentation of emerging 
themes to clinical colleagues to assess whether these resonated with their clinical experiences. 
Statistical analysis of CBT intervention 
Summary measures for participants’ characteristics were presented as means and standard 
deviations for continuous (approximately) normally distributed variables, frequencies and 
percentages for categorical variables. No formal statistical tests were carried out in this analysis 
and patient data were individually assessed for the series of case studies.   
Health economics  
A descriptive analysis of the health economic data was conducted due to the small size of the 
sample. The information provided includes the number of patients using different health and 
social services, and the mean cost across the sample with standard deviations.   
Results 
Telephone interviews 
A total of 12 patients took part in the telephone interviews; socio-demographic information of 
participants is shown in Table 2.  
(Table 2 about here) 
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From the qualitative framework analysis four main themes emerged: (i) the importance of 
emotional support as part of a comprehensive outpatient service; (ii) past experiences of 
psychological support;  (iii) logistics of the delivery (location, health professional, timing); and 
(iv) the value of an additional psychological service to outpatient attendees with RA.  
There were no differences in the accounts in relation to age, gender and ethnicity. The majority 
(9/12) of patients would welcome emotional support in groups, by telephone or face to face 
consultations. 
“….the thing that frustrates me is the unknown if you know what I mean; you feel good 
one day and then all of a sudden it [RA] can just knock you for six, so if I got somebody 
to talk to about that, I suppose it probably would make me feel better, to air my 
problems I suppose” . (Patient 8)  
The majority of patients (10/12) talked about the informal support they received from family 
members or formally from health professionals and some (3/12) found professional emotional 
guidance either helpful or not. 
“My family really, [support me] …yeah they tend to cheer me up a bit, they help me, 
you know”. (Patient 2) 
“Well I’ve only had a few sessions [with a psychologist] but it’s helped a lot”. 
(Patient 7) 
“I was referred to counselling, which I have to put in a comment…. it was appalling, 
absolutely appalling”. (Patient 9) 
All participants suggested flexibility for the location (e.g. in hospital, separate from outpatient 
clinic, family doctor venue, community centre) with a trained clinical psychologist, ideally 
with specific knowledge of RA. 
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 “It is down to the individual, whatever works for everybody”. (Patient 1) 
 “I would think when you kind of got over the shock, you have accepted it [diagnosis of 
RA] but you are now realising the limits and what you can and cannot do” [therefore 
emotional support would be valuable]. (Patient 4)  
“When I was first diagnosed I was upset, I was devastated… then I could have done 
with it [emotional support]… when you are diagnosed you definitely, desperately need 
it [emotional support]”. (Patient 12) 
Study participants for the CBT intervention 
Five patients completed the baseline assessment. Three patients completed the intervention.  
Individual patients’ results  
The three patients with complete follow-up data showed different patterns in terms of visual 
analogue domains (Figure 1). Patient one showed a good deal of variation for all the 
dimensions.  Impact of pain was lowest at baseline and 6 months follow-up, while coping 
appeared increased in the last two time points. Patient two showed less variation, coping and 
mood were lowest at baseline. Mood was lower at 6 weeks follow-up, but higher at the 6 month 
point. All the domains showed improvement during the intervention period. Patient three 
started with some higher scores at baseline. The impact of pain and fatigue showed marked 
decrease and were the lowest at 6 weeks post intervention, but showed marked increase at 6 
months follow up. Coping levels were lowest at assessment and a general trend of increased 
coping is discernible. (Figure 1 about here) 
 
Figure 2 shows the HADS for the three patients. There was no change in patient one, while 
patients 2 and 3 started with a higher value of HADs with a reduction of their HADS in the 
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post intervention period. This suggests that these patients 2 and 3 may have benefited from the 
intervention as their HADS stayed low at 6 months follow up. There was no change in HAQ 
and EQ5D during follow-up; in addition, there was no change in coping strategies (results not 
shown here). (Figure 2 about here) 
Health economic results 
Of the 5 patients who completed the baseline assessments, three completed the intervention 
and therefore data was collected on services used and therapist’s time at all three time points. 
All patients used relatively the same amount and types of services over the three data collection 
time points (see Table 3).   
(Table 3 about here) 
Patients visited the hospital for a wide range of reasons which could not be directly attributed 
to RA at baseline. No further use was made of hospital-based services at the end of treatment 
and at 6-months follow up. Consistently, across all three time points all patients visited the 
Outpatient Rheumatology Department for regular reviews, blood tests and one patient had an 
emergency appointment. The average costs of Rheumatology department contacts for the study 
time period were £180, £67 and £100 at baseline, end of treatment and at 6-months follow up 
respectively.  
Family doctor and dental services were the most frequently used of all community-based 
services. Visits to the rheumatology specialist nurse, occupational therapist and optician took 
place only at 6-months follow-up. The average costs of family doctor contacts were £137, £12, 
and £1,002 at baseline, end of treatment and at 6-months follow-up respectively for each 
participant. The high primary care costs (£1,002) at 6-month follow-up were due to frequent 
Family doctor visits. The average costs for dental services were fairly similar across the 3-time 
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points. The average total cost at baseline and at 6-month follow-up for patients with costs at all 
3-time points was £924 at baseline and £1,782 at follow-up.  
The average time the psychologist spent with individual patients in each treatment session was 
55 minutes, with an average cost per session of £102 (Table 4). (Table 4 about here).  In 
addition to treatment sessions, the psychologist also spent time on a) non face-to-face contact 
with patients (e.g. email), and b) patient-related activities (e.g. finding information, discussions 
with colleagues, making telephone calls). The average time spent on other activities in each 
session (and cost) was 3 minutes (£6) and 64.5 minutes (£53) respectively. 
Discussion 
This mixed methods study was conducted mainly as a case series feasibility design relying on 
a descriptive data analysis, with eight data time points completed for three patients with 
established RA over a six months period, including a formative qualitative study and health 
economic evaluation. It is a small feasibility study and comments about the efficacy of the 
intervention cannot therefore be provided.  
The formative qualitative study indicated that although the majority of participants received 
informal support from friends, family and from healthcare professionals, many would welcome 
additional emotional guidance, ideally from a healthcare professional who has knowledge 
about RA. Patients rightly identified that physical and psycho-social health need to be 
addressed during consultations, which resonates well with previous publications (Dures et al., 
2014; Gettings, 2010) and published recommendations (Wagner et al., 2001). 
A number of key points emerged during the CBT intervention that are relevant for future 
psychological studies involving in patients with established RA. The study psychologist 
embraced a  (i) broad psycho-social  approach i.e. ,  not only focusing on medication adherence 
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in response to the qualitative feedback by patients during  the pilot study (Ferguson et al., 
2015), as mentioned above.  The results from the three patients suggested that they may have 
benefitted from the holistic intervention until to the point of the follow-up (but we cannot 
comment on the efficacy of the intervention). (ii) In addition, sustained self-management 
through extended telephone, digital health technology or individual booster appointments 
during the follow up period with the clinical psychologist is proposed for future studies.  
Weekly face to face sessions with the clinical psychologist were too demanding on patients 
varies competing domestic, work and illness specific self-management commitments, therefore 
a (iii) flexible appointment system during the study will allow patients to accommodate all 
aspects of their lives and incorporate ‘practice of homework’ agreed during the CBT  session.     
The results of the economic component of this study need to be interpreted with caution. 
Although this sample size does not allow us to draw firm conclusions regarding service gaps, 
it was nevertheless notable that none of our participants made contact with specialist 
physiotherapist or podiatrist six months pre and post treatment despite these being clearly 
recommended components of NICE treatment guidelines for RA (The National Institute for 
Health and Care Excellence, 2009).  Our findings therefore generate the hypothesis, to be tested 
in future studies, that patients with established RA will show improvements in their psycho-
social health when treated individually with CBT. The practice implications of this study are 
that patients with RA may benefit from psychological interventions to cope better with their 
long-term condition. Intervention studies are necessary to test this question. The integration of 
a clinical psychologist in an outpatient Rheumatology clinic team may be required to provide 
a more holistic approach within Rheumatology services to improve physical and psycho-social 
health. 
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Figures 1: Mean Visual analogue scales domains by follow-up time in Patients 1-3  
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Figures 2: Follow-up measurements of HAD, HAQ, Quality of Life and RA Self-Efficacy  
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Table 1. Summary Table of questionnaires and administration time-points 
 S* 0 1 2 3 4 5 6 7 8 
Measures           
EuroQol (EQ–5D)39  x      x  x 
HAQ 40  X      x  x 
HADS 38 x       x  x 
IPQ-RA41  X      x  x 
RASE 42  X      x  x 
CSQ43  X      x  x 
VAS Coping  x x x x X x x x x 
VAS QoL  x x x x X x x x x 
VAS Fatigue  x x x x X x x x x 
VAS Pain  x x x x X x x x x 
VAS Mood  x x x x X x x x x 
CSRI 44  x      x  x 
*S=Screening 
Hospital Anxiety and Depression Scale (HADS )(Huston, 1987) 
EuroQol (EQ–5D-3L) measures quality of life. (The EuroQol, 1990) 
Health Assessment Questionnaire (HAQ) (Fries, Spitz, Kraines, & Holman, 1980) which measure disability.  
Illness Perceptions Questionnaire –Revised for Rheumatoid Arthritis (IPQ-R for RA)(Moss-Morris et al., 2002). 
This measures illness beliefs.  
Rheumatoid Arthritis  Self-efficacy scale (RASE) (Hewlett et al., 2001) 
Coping Strategies Questionnaire (CSQ) (Rosenstiel & Keefe, 1983) 
Five single-item visual analogue scales (VAS) were also completed, assessing current levels of: coping, QoL, 
fatigue, pain, mood (Wewers & Lowe, 1990) 
Client Service Receipt Inventory (CSRI) (Beecham & Knapp, 1992). Health Economic questionnaire to measure 
health service use. 
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Table 2: Socio-demographic data of 12 participants of telephone interview study 
Gender 8 female/4male 
Age range: 27-83 yrs. mean: 57 yrs.  
Duration of RA  range: 2-40 years, mean: 13 years  
 
Marital status  4 married, 3 separate/divorced, 3 cohabiting,  1 
single, 1 unspecified  
 
Dependents  1 yes, 11 no  
 
Employment status  5 retired, 4 FT, 2PT, 1 other  
 
Place of Birth  9 UK, 3 outside UK  
 
Self-defined ethnicity  7 Caucasians, 5 Black and ethnic community  
 
Registered Disabled  4 yes, 6 no, 2 unspecified  
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Table 3.  Health and social care service use and costs 
 
Services Baseline* Following completion of 
session^ 
6 months follow-up^ 
n 
using  
(%) 
Mean 
cost,  
 (£) 
(SD)  n 
using 
 (%) 
Mean 
cost, 
 (£) 
(SD)  n using  
(%) 
Mean 
cost,  
 (£) 
(SD)  
Hospital-based 
services§ 
         
Inpatient stay 1 (20) 97 (216) - - - - - - 
Emergency 
department 
1 (20) 371 (829) - - - - - - 
Day surgery 1 (20) 26 (58) - - - 1 (33) 44 (76) 
Rheumatology 5 
(100) 
180 (84) 2 (67) 67 (58) 3 (100) 100 (0) 
Other outpatient 
services 
- - - - - - 2 (67) 233 (321) 
Other outpatient 
services 
- - - - - - 2 (67) 233 (321) 
Other hospital based 
services 
- - - 1 (33) 74 (128) 1 (33) 80 (139) 
Community-based 
services§ 
         
General practitioner 4 (80) 137 (131) 1 (33) 12 (21) 3 (100) 1,002 (1,642) 
Practice Nurse 1 (20) 63 (142) - - - 1 (33) 26 (46) 
Rheumatology 
specialist nurse 
- - - - - - 2 (67) 11 (10) 
Occupational 
Therapist 
- - - - - - 2 (67) 188 (229) 
Dentist 2 (40) 66 (107) 1 (33) 82 (142) 2 (67) 82 (82) 
Optician - - - - - - 1 (33) 7 (12) 
Social worker 1 (20) 838 (1874) - - - 1 (33) 10 (16) 
Total costs   1777 (2104)  235 (94)  1782 (1778) 
*Total number of patients at baseline was 5; ^Total number of patients following completion of therapy and at 6 
months follow-up was 3 §Hospital-based services cost are in 2012/13 £s; Community-based services cost are in 
2014 £s 
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Table 4. Therapy time inputs and costs 
 
Session 
number* 
Treatment session Other contact time related  
to treatment session 
Non-contact time related  
to treatment session 
Mean duration 
(SD) in 
minutes 
Mean cost, 
£ (SD) 
Mean duration 
(SD) in 
minutes 
Mean 
cost, £ 
(SD) 
Mean duration 
(SD) in 
minutes 
Mean cost, 
£ (SD) 
1 57 (6) 105 (11) 0 0 90 (0) 74 (0) 
2 60 (0) 111 (0) 0 0 60 (0) 49 (0) 
3 60 (0) 111 (0) 3 (6) 6 (11) 60 (0) 49 (0) 
4 60 (0) 111 (0) 7 (6) 12 (11) 63 (6) 52 (5) 
5 55 (9) 102 (16) 10 (10) 19 (19) 57 (6) 46 (5) 
6 40 (35) 74 (64) 0 0 57 (49) 46 (40) 
Average total 
across the 6 
sessions 
332 (49) 614 (91) 20 (17) 37 (32) 387 (49) 317 (40) 
*Total number of patients was 3 except for session 6 with 2 participants. Costs are in 2014 price levels 
